
GHRS vs JBIO
$GHRS vs $JBIO head to head: price, market cap, valuation, dividend, free float, relative volume and how actively each trades. The bigger value in the size rows is bolded. Tap either ticker for its live chart, full ownership breakdown and real-time alerts.
GHRS vs JBIO: the quick read
- ·GHRS is the larger company by market cap ($1.14B vs $897M).
- ·JBIO has been more active on our scanner (133 vs 97 alerts in 30 days).
- ·GHRS has the smaller float (46.5M vs 50.2M), which tends to mean sharper, more volatile moves.
- ·Both are pharmaceutical preparations names, so this is a like-for-like comparison and sector news tends to move them together.
- ·Both stay busy on our scanner, 133 and 97 unusual-volume alerts over 30 days, so neither is the quiet one here.
- ·They are closely matched in size, within 28% of each other on market cap, which makes the rest of this table the interesting part.
Objective differences only. Not investment advice.
Get the best catches in your inbox
Free daily email of the top plays and unusual-volume alerts our scanner flags. No account needed.
No spam. Unsubscribe anytime. Not investment advice.
Frequently asked questions
Everything you need to know comparing GHRS and JBIO on TheDesperateTrader.
- Is GHRS or JBIO the better stock?
- "Better" depends on your goal, and these two are not alike. GHRS is the larger company by market cap ($1.14B vs $897M). JBIO has been more active on our scanner (133 vs 97 alerts in 30 days). GHRS has the smaller float (46.5M vs 50.2M), which tends to mean sharper, more volatile moves. Those are the measured differences, not a recommendation, and nothing here is investment advice.
- What is the difference between GHRS and JBIO?
- The differences that matter: they are similar in size ($1.14B vs $897M); they trade at very different share prices ($18.44 vs $14.10); GHRS sits at 33% of its 52-week range against 29% for JBIO; our scanner flagged GHRS 97 times in the last 30 days against 133 for JBIO. Everything above is measured from the latest completed session and SEC filings.
- Which of GHRS and JBIO is more active right now?
- Right now GHRS is at about 1.2x its normal volume and JBIO is at about 1.4x, so JBIO is the one drawing unusual attention today. Relative volume (RVOL) compares a stock's volume to its own recent average, so it reads the same way for a megacap and a microcap and is the quickest way to tell which of two similar names is actually in play.
- Is this comparison data live?
- Prices and % changes are anchored to the latest completed session and split-adjusted, so a reverse split never shows as a fake move. Float is estimated from SEC filings and refreshed as new filings publish.
Trading GHRS or JBIO? Get real-time unusual-volume alerts the moment either one moves, free.
No card · 5 premium daysMore GHRS and JBIO comparisons
Same sector, similar size. These are the peers each one is usually weighed against.
Explore the market
Free, live market tools. No account required to look.